If you made any changes in Pure these will be visible here soon.

Publications 2005 2009

2009

Siprofloksasiini ja fluvoksamiini voivat aiheuttaa vaarallisia CYP1A2 - välitteisiä yhteisvaikutuksia: [lääkeinfo]

Jaakkola, T., Backman, J. T., Palva, E. & Neuvonen, P., 2009, In : Suomen lääkärilehti. 64, 45, p. 3866-3869 4 p.

Research output: Contribution to journalArticleScientific

2007

Pharmacokinetic interactions of pioglitazone

Jaakkola, T., 2007, Helsinki: [T. Jaakkola]. 70 p.

Research output: ThesisDoctoral ThesisCollection of Articles

2006

Effect of rifampicin on the pharmacokinetics of pioglitazone

Jaakkola, T., Backman, J. T., Neuvonen, M., Laitila, J. & Neuvonen, P. J., 2006, In : British Journal of Clinical Pharmacology. 61, 1, p. 70-78 9 p.

Research output: Contribution to journalArticleScientificpeer-review

Montelukast and zafirlukast do not affect the pharmacokinetics of the CYP2C8 substrate pioglitazone

Jaakkola, T., Backman, J. T., Neuvonen, M., Niemi, M. & Neuvonen, P. J., 2006, In : European Journal of Clinical Pharmacology. 62, 7, p. 503-509 7 p.

Research output: Contribution to journalArticleScientificpeer-review

Pioglitazone is metabolised by CYP2C8 and CYP3A4 in vitro: potential for interactions with CYP2C8 inhibitors

Jaakkola, T., Laitila, J., Neuvonen, P. J. & Backman, J. T., 2006, In : Basic & Clinical Pharmacology & Toxicology. 99, 1, p. 44-51 8 p.

Research output: Contribution to journalArticleScientificpeer-review

2005

Effects of gemfibrozil, itraconazole, and their combination on the pharmacokinetics of pioglitazone

Jaakkola, T., Backman, J. T., Neuvonen, M. & Neuvonen, P. J., 2005, In : Clinical Pharmacology and Therapeutics. 77, 5, p. 404-414 11 p.

Research output: Contribution to journalArticleScientificpeer-review